JOYLUCKY Group was established in 2002, has been focusing on the research and promotion of biotechnology and pharmaceutical health products for a long time. Innovative technology as the core, with the combination of industry, universities and research institute to create a professional brand. In the fields of biomedicine, immune cells, genetic engineering, medical testing, medical cosmetology etc. JOYLUCKY has achieved remarkable achievements and was listed as a national high-tech enterprise in 2020.

JOYLUCKY has established a comprehensive marketing system nationwide, with over 3000 high-quality medical and medical professional institutions distributed throughout the country, and its business network covering more than 30 provinces, cities, and autonomous regions. In the pharmaceutical field, JOYLUCKY uses its core enterprise - Zhejiang A-timely medical Co., Ltd. - as a strategic platform for research and sales, continuously exporting high-quality products and services, especially in the fields of pediatrics, central nervous system, and other drugs. For many years, JOYLUCKY has maintained a leading market position in the industry.

In terms of scientific research and academia, JOYLUCKY adheres to an international perspective and established a global medical research center in Europe in 2003. It also collaborates with well-known domestic universities (Fudan University, Shanghai JiaoTong University, East China University of Science and Technology, China Pharmaceutical University, Central South University, etc.) to carry out industry-university-research cooperation; Maintain academic cooperation with national first level units such as the Chinese Medical Association, the Chinese Medical Association, and the China Association for the Prevention and Control of Drug Abuse, and effectively promote and implement the system of standardized drug use; We have successively established and improved a medical expert resource center covering the whole country.

In the field of smart medical care, JOYLUCKY has built a smart medical care industry platform based on Ningbo Iris Technology Co., Ltd., launched hospital level intelligent medical material programs, AI intelligent pharmacy operation programs, and smart ward management programs, providing safe and efficient intelligent medical service integration systems for medical service institutions at all levels.

In the field of medical testing, JOYLUCKY also adheres to the development strategy of integrating industry, academia, and research. As the first “subcellular structural damage detection project developed based on flow cytometry technology” project in China, it is currently at the leading level in the domestic industry.

In 2022, JOYLUCKY Group will layout the Iris Smart Medical Industry Park in Ningbo High tech Zone, with an initial investment of over 600 million Chinese yuan. The park will be designed by famous masters from the Landscape Architecture Design Institute of the Chinese Academy of Fine Arts, with an operating area of 50000 square meters. It plans to build JOYLUCKY International Biomedical Research Center, Smart Medical Equipment Production Center, Cell Medicine Reagent Production and Testing Center, JOYLUCKY Business School, and JOYLUCKY Academician Workstation,such that entities with the JOYLUCKY Medical Industry Alliance.

Strong team execution and corporate cohesion are the guarantees for the sustainable development of JOYLUCKY. We adhere to the corporate spirit of "affinity, responsibility, and efficiency", continuously build the core competitiveness of the enterprise, create a happiness enterprise, and strive to achieve the common values of partners, employees, and the company. Lastly, we will never forget our original intention --- take public health as our responsibility, and provide high-quality products and services to make people's lives better.